Target intelligence / Profile preview

Pathogenic Autoantibody (N/A)

Target
N/A
Molecular classification
Immunoglobulin, Antibody
01

Overview

Pathogenic autoantibodies are antibodies produced by the immune system that mistakenly target and bind to the body’s own proteins, cells, or tissues (self-antigens), leading to inflammation, tissue injury, and a range of autoimmune diseases. They are often high-affinity IgG molecules that arise due to a breakdown in self-tolerance mechanisms and can cause disease through various mechanisms, including disrupting normal protein function, forming immune complexes, activating complement, and inducing altered signaling pathways. Their identification is crucial for diagnosis, monitoring disease progression, and developing targeted therapies for autoimmune disorders.

Other names
AutoantibodyDisease-causing autoantibodySelf-reactive antibody
02

Mechanism of action

Varies depending on the specific autoantibody and its target. Examples include: B cell depletion, complement inhibition, immunosuppression, neutralization of autoantibody, blockade of receptor signaling.

03

Biological functions

Immune response (dysregulated)Target recognition (self-antigen)Complement activationAntibody-dependent cell-mediated cytotoxicity (ADCC)Immune complex formation
04

Disease associations

Autoimmune diseaseInflammationTissue damageMyasthenia gravisPemphigusGraves’ diseaseMembranous nephropathyNeuromyelitis opticaRheumatoid arthritis
05

Safety considerations

Immunosuppression (increased risk of infection)Infusion reactionsDevelopment of secondary autoimmune diseasesOpportunistic infectionsDrug-specific adverse effects
06

Interacting drugs

Rituximab (B cell depletion)

5 more in the full profile.

07

Biomarkers

Autoantibody titerAnti-acetylcholine receptor antibody (Myasthenia gravis)Anti-desmoglein-3 antibody (Pemphigus)Anti-TSH receptor antibody (Graves’ disease)Anti-aquaporin-4 antibody (Neuromyelitis optica)Anti-citrullinated protein antibodies (Rheumatoid arthritis)

Beyond the preview

Go deeper on Pathogenic Autoantibody (N/A).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Pathogenic Autoantibody (N/A).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call